Significance of multiple sclerosis early treatment
Author:
Open Access
- 1 September 2019
- journal article
- Published by Solen s.r.o. in Neurologie pro praxi
- Vol. 20 (4) , 288-290
Abstract
Sclerosis multiplex je chronické ochorenie postihujúce najmä mladých dospelých ľudí. Správne načasovanie liečby určuje ďalší priebeh ochorenia a pozitívne ovplyvňuje kvalitu života. Práca prináša nové pohľady na diagnostikuKeywords
This publication has 15 references indexed in Scilit:
- B cells as a target in the treatment of multiple sclerosisNeurologie pro praxi, 2017
- Ocrelizumab versus Placebo in Primary Progressive Multiple SclerosisNew England Journal of Medicine, 2017
- Mechanisms of glutamate toxicity in multiple sclerosis: biomarker and therapeutic opportunitiesThe Lancet Neurology, 2016
- Transcription factor Nr4a1 couples sympathetic and inflammatory cues in CNS-recruited macrophages to limit neuroinflammationNature Immunology, 2015
- Oral treatment for multiple sclerosisThe Lancet Neurology, 2011
- Multiple sclerosis: current treatment algorithmsCurrent Opinion in Neurology, 2011
- Diagnostic criteria for multiple sclerosis: 2010 Revisions to the McDonald criteriaAnnals of Neurology, 2011
- Disability and T2 MRI lesions: a 20-year follow-up of patients with relapse onset of multiple sclerosisBrain, 2008
- Advances in multiple Sclerosis and Experimental Demyelinating Diseases2008
- Heterogeneity of multiple sclerosis pathogenesis: implications for diagnosis and therapyTrends in Molecular Medicine, 2001